Aptamers-based drug: A new paradigm for precise treatment
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Protein Degradation and Inhibitors
Advanced Breast Cancer Therapies
Publication details
- Journal / source
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Volume
- 307
- Pages
- 118683–118683
- Publication date
- 13 February 2026
- Language
- EN